Overview
Status
Suspended
Registry date
2022-02-18
Share capital
50 000,00 PLN
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 3 financial statements was filed late (for 2022, 985 days late).
- 2025not filed
- 202411/07/2025
- 2023filed
- 202226/03/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 1.09mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 44.58kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 1.03mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 71.15kMedianUSD 609.79kAverageUSD 11.85m
Industry
General partners
Filip Błaszkowskiage 42
Manner of representation
Independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2022-03-01 to 2026-02-09.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| NeucaS.A. | $3,426,322,199.90 | inwestor.neuca.pl | ||
| Dutchmed Plsp. z o.o. | $6,460,098.71 | dutchmed.pl | ||
| Przedsiębiorstwo Handlowe Linessp. z o.o. | $5,548,056.66 | lines.com.pl | ||
| Strażaksp. z o.o. | $3,098,112.37 | strazak.torun.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Zbadajsiesp. z o.o. | $1,112,372.08 | labhome.pl | ||
| Medaidsp. z o.o. | $1,034,514.88 | medaid.pl | ||
| Polcoresp. z o.o. | $1,015,341.48 | polcore.pl | ||
| Panacea-Diagnostykasp. z o.o. | $270,780.69 | panacea.net.pl | ||
| Mimic Polandsp. z o.o. | $85,589.70 | mimic.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-25 | Business suspended | |
| 2023-07-31 | Business resumed | |
| 2022-06-01 | Business suspended | |
| 2022-02-18 | Entered in the register |
FAQ
The main business activity of Monfil Filip Błaszkowski focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 18, 2022.
The headquarters is located at: ul. Starowiejska 70, 86-014 Osówiec.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $1,092,660 in 2024, which is an increase of 1402.9% compared to 2023.
Yes, in 2024 the company achieved a net profit of $44,577.
The largest operating cost category falls under materials and energy. This category amounted to $1,001,522 in 2024, representing 97% of all operating expenses.
Last updated: 2026-04-01